Paradigm Capital Management Inc’s Bristol-Myers Squibb BMY Stock Holding History

Paradigm Capital Management Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294K	Hold	5,100	–	–	0.01%	110
2026 Q1	$309K	Hold	5,100	–	–	0.01%	108
2025 Q4	$275K	Hold	5,100	–	–	0.01%	111
2025 Q3	$230K	Hold	5,100	–	–	0.01%	123
2025 Q2	$236K	Sell	5,100 -5,000	-50%	-$245K	0.01%	118
2025 Q1	$616K	Hold	10,100	–	–	0.03%	102
2024 Q4	$571K	Hold	10,100	–	–	0.03%	104
2024 Q3	$523K	Hold	10,100	–	–	0.02%	112
2024 Q2	$419K	Hold	10,100	–	–	0.02%	121
2024 Q1	$548K	Sell	10,100 -200	-2%	-$10.2K	0.03%	111
2023 Q4	$528K	Hold	10,300	–	–	0.03%	114
2023 Q3	$598K	Hold	10,300	–	–	0.03%	115
2023 Q2	$659K	Buy	10,300 +100	+1%	+$6.71K	0.04%	112
2023 Q1	$707K	Hold	10,200	–	–	0.05%	111
2022 Q4	$734K	Hold	10,200	–	–	0.05%	112
2022 Q3	$725K	Hold	10,200	–	–	0.05%	108
2022 Q2	$785K	Hold	10,200	–	–	0.05%	108
2022 Q1	$745K	Hold	10,200	–	–	0.04%	116
2021 Q4	$636K	Sell	10,200 -200	-2%	-$11.7K	0.03%	131
2021 Q3	$615K	Hold	10,400	–	–	0.03%	128
2021 Q2	$695K	Hold	10,400	–	–	0.03%	132
2021 Q1	$657K	Sell	10,400 -2,000	-16%	-$124K	0.03%	127
2020 Q4	$769K	Hold	12,400	–	–	0.05%	123
2020 Q3	$748K	Hold	12,400	–	–	0.06%	115
2020 Q2	$729K	Hold	12,400	–	–	0.07%	112
2020 Q1	$691K	Buy	12,400 +600	+5%	+$36.7K	0.08%	109
2019 Q4	$757K	Buy	11,800 +1,000	+9%	+$57.3K	0.06%	119
2019 Q3	$548K	Buy	+10,800	New	+$508K	0.05%	129

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Paradigm Capital Management Inc's BMY Position: Q2 2026 in Review

Paradigm Capital Management Inc held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,100 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #110.

Paradigm Capital Management Inc first reported a position in BMY in Q3 2019 and has held it in 28 quarters since. The position peaked at $785K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Paradigm Capital Management Inc held 5,100 shares of Bristol-Myers Squibb worth $294K as of Q2 2026.
Paradigm Capital Management Inc left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Paradigm Capital Management Inc's portfolio in Q2 2026, its #110 holding.
Paradigm Capital Management Inc first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 28 quarters since.
Paradigm Capital Management Inc's Bristol-Myers Squibb position peaked at $785K in Q2 2022.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2026, filed 13 Aug 2026.